WO2010049590A3 - A new pharmaceutical product - Google Patents
A new pharmaceutical product Download PDFInfo
- Publication number
- WO2010049590A3 WO2010049590A3 PCT/FI2009/050869 FI2009050869W WO2010049590A3 WO 2010049590 A3 WO2010049590 A3 WO 2010049590A3 FI 2009050869 W FI2009050869 W FI 2009050869W WO 2010049590 A3 WO2010049590 A3 WO 2010049590A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue
- collagenous protein
- blood circulation
- pharmaceutical product
- new pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
- C12Y114/11004—Procollagen-lysine 5-dioxygenase (1.14.11.4), i.e. lysine-hydroxylase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
The present invention relates to methods and products for the treatment of any disorder or condition, which is associated with abnormal amount of non-collagenous protein, or abnormal oligomerization or dysfunction of non-collagenous protein, such as adiponectin in the blood circulation and/or tissue of a patient. The treatment comprises that functional form of the non-collagenous protein is adjusted in the blood circulation and/or tissue of the patient substantially to the level it is in the blood circulation and/or tissue of a healthy person, by using lysyl hydroxylase and/or glycosyl-transferase activities of LH3 or other lysyl hydroxylase to modify the non-collagenous protein to HMW or other functional form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09759744A EP2349326A2 (en) | 2008-10-29 | 2009-10-29 | A new pharmaceutical product |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19764208P | 2008-10-29 | 2008-10-29 | |
FI20086024 | 2008-10-29 | ||
US61/197,642 | 2008-10-29 | ||
FI20086024A FI20086024A0 (en) | 2008-10-29 | 2008-10-29 | New pharmaceutical product |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010049590A2 WO2010049590A2 (en) | 2010-05-06 |
WO2010049590A3 true WO2010049590A3 (en) | 2010-06-24 |
Family
ID=39924662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2009/050869 WO2010049590A2 (en) | 2008-10-29 | 2009-10-29 | A new pharmaceutical product |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2349326A2 (en) |
FI (1) | FI20086024A0 (en) |
WO (1) | WO2010049590A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012139866A1 (en) * | 2011-04-15 | 2012-10-18 | Universität Zürich Prorektorat Mnw | Collagen hydroxylases |
GB201202561D0 (en) * | 2012-02-15 | 2012-03-28 | Univ Dundee | Treatment of skin disorders |
WO2022224015A1 (en) * | 2021-04-21 | 2022-10-27 | University Of Hong Kong | Adiponectin glycopeptides and compositions and methods of use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117950A2 (en) * | 2004-05-28 | 2005-12-15 | The Regents Of The University Of California | Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity |
WO2007146171A2 (en) * | 2006-06-08 | 2007-12-21 | Trustees Of Tufts College | Purified high molecular weight adiponectin and uses thereof |
WO2009080899A2 (en) * | 2007-12-21 | 2009-07-02 | Oulun Yliopisto | Products and methods affecting cell and tissue growth |
-
2008
- 2008-10-29 FI FI20086024A patent/FI20086024A0/en not_active Application Discontinuation
-
2009
- 2009-10-29 WO PCT/FI2009/050869 patent/WO2010049590A2/en active Application Filing
- 2009-10-29 EP EP09759744A patent/EP2349326A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117950A2 (en) * | 2004-05-28 | 2005-12-15 | The Regents Of The University Of California | Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity |
WO2007146171A2 (en) * | 2006-06-08 | 2007-12-21 | Trustees Of Tufts College | Purified high molecular weight adiponectin and uses thereof |
WO2009080899A2 (en) * | 2007-12-21 | 2009-07-02 | Oulun Yliopisto | Products and methods affecting cell and tissue growth |
Non-Patent Citations (3)
Title |
---|
RICHARDS A A ET AL: "ADIPONECTIN MULTIMERIZATION IS DEPENDENT ON CONSERVED LYSINES IN THE COLLAGENOUS DOMAIN: EVIDENCE FOR REGULATION OF MULTIMERIZATION BY ALTERATIONS IN POSTTRANSLATIONAL MODIFICATIONS", MOLECULAR ENDOCRINOLOGY, THE ENDOCRINE SOCIETY, US LNKD- DOI:10.1210/ME.2005-0390, vol. 20, no. 7, 1 July 2006 (2006-07-01), pages 1673 - 1687, XP009071842, ISSN: 0888-8809 * |
WANG YU ET AL: "Post-translational modifications of adiponectin: mechanisms and functional implications", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB LNKD- DOI:10.1042/BJ20071492, vol. 409, no. 3, 1 February 2008 (2008-02-01), pages 623 - 633, XP009132821, ISSN: 0264-6021 * |
WANG YU ET AL: "Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.M513907200, vol. 281, no. 24, 18 April 2006 (2006-04-18), pages 16391 - 16400, XP002458709, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010049590A2 (en) | 2010-05-06 |
EP2349326A2 (en) | 2011-08-03 |
FI20086024A0 (en) | 2008-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200740804A (en) | Glucokinase activators | |
WO2007128817A3 (en) | Insulin derivative | |
EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
DE602006007093D1 (en) | Combination therapy for the treatment of diabetes and related conditions as well as for the treatment of conditions that have been improved in the blood by increasing GLP-1 levels | |
EA201170149A1 (en) | NEW ANALOGUES INSULIN OF PROLONGED ACTIVITY | |
EP3050876A3 (en) | Kinase modulators | |
WO2007117381A3 (en) | 2 -aminopyridine analogs as glucokinase activators | |
EP2532657A3 (en) | Compounds and methods of use | |
EA201691260A1 (en) | OPTIONS FROM ACTRIIB, AND THEIR APPLICATION | |
WO2009130198A3 (en) | Hyperglycosylated human coagulation factor ix | |
WO2008118718A3 (en) | 2-aminopyridine analogs as glucokinase activators | |
MX340515B (en) | Vasoprotective and cardioprotective antidiabetic therapy. | |
WO2010065671A3 (en) | Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf | |
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
BRPI0909447A2 (en) | Composition, methods for treating a human or animal subject in need of such treatment and for killing or inhibiting the growth of susceptible microorganisms, and use of a composition. | |
WO2010071826A3 (en) | Methods for treating osteoclast-related disease, compounds and compositions thereof | |
MX2010009743A (en) | Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members. | |
WO2008096203A3 (en) | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders | |
EA201291167A1 (en) | SUBSTITUTED HETEROCYCLYLBENZYLPYRAZOLES AND THEIR APPLICATION | |
EP3318251A3 (en) | Composition for preventing or treating obesity or lipid-related metabolic disease | |
MX2007011264A (en) | Nutritional compositions for modulating vitamin c bio-availability. | |
BR112013030171A2 (en) | edible composition, method for reducing peak postprandial blood glucose amplitude or glycemic response in a non-diabetic person, method for treating a person in need of type 2 diabetes treatment, and use of the composition | |
WO2010049590A3 (en) | A new pharmaceutical product | |
WO2008066775A3 (en) | Compositions and methods to reduce fat and retract skin | |
WO2007100430A3 (en) | Cytisine and acetylcholine analogs and methods of treating mood disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09759744 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009759744 Country of ref document: EP |